This regulatory network was inferred from the input dataset. The miRNAs and mRNAs are
presented as round and rectangle nodes respectively. The numerical value popped up upon mouse over the gene node is the log2 transformed fold-change of the gene expression between the two groups. All of the nodes are clickable, and the detailed information of the miRNAs/mRNAs and related cancer pathway will be displayed in another window. The edges between nodes are supported by both interactions (predicted or experimentally verified) and correlations learnt from cancer dataset. The numerical value popped up upon mouse over the edge is the correlation beat value (effect size) between the two nodes. The experimental evidences of the edges reported in previous cancer studies are highlighted by red/orange color. All of these information can be accessed by the "mouse-over" action. This network shows a full map of the miRNA-mRNA regulation of the input gene list(s), and the hub miRNAs (with the high network degree/betweenness centrality) would be the potential cancer drivers or tumor suppressors. The full result table can be accessed in the "Regulations" tab.
"miRNACancerMAP" is also a network visualization tool for users to draw their regulatory network by personal customization. Users can set the complexity of the network by limiting the number of nodes or edges. And the color of the nodes can be defined by different categories of the mRNAs and miRNAs, such as Gene-Ontology, pathway, and expression status. Users can also select to use network degree or network betweenness centrality to define the node size. And edges can be black or colored by the correlation. Purple edge means negative correlation (mostly found between miRNA and mRNA), and blue edge means positive correlation (found in PPI or miRNA-miRNA sponge effect). We can also add the protein-protein interactions (PPI) into the network. This result will show the cluster of genes regulated by some specific miRNAs. Additionally, miRNA-miRNA edges can be added by the "miRNA sponge" button, presenting some clusters of miRNAs that have the interactions via sponge effect.
Num | microRNA | Gene | miRNA log2FC | miRNA pvalue | Gene log2FC | Gene pvalue | Interaction | Correlation beta | Correlation P-value | PMID | Reported in cancer studies |
---|---|---|---|---|---|---|---|---|---|---|---|
1 | hsa-miR-17-5p | ABCD2 | 2.33 | 0.30125 | -2.73 | 0.01225 | MirTarget | -0.54 | 0 | NA | |
2 | hsa-miR-17-5p | ABHD2 | 2.33 | 0.30125 | 0.09 | 0.9591 | TargetScan; miRNATAP | -0.18 | 0.00209 | NA | |
3 | hsa-miR-32-5p | ABI3BP | 2.95 | 0.02657 | -4.96 | 5.0E-5 | miRNATAP | -0.32 | 0.02411 | NA | |
4 | hsa-miR-32-5p | ABLIM1 | 2.95 | 0.02657 | -0.22 | 0.91084 | mirMAP | -0.34 | 1.0E-5 | NA | |
5 | hsa-miR-454-3p | ACSL1 | 1.37 | 0.14233 | -0.18 | 0.89649 | MirTarget | -0.21 | 0.00407 | NA | |
6 | hsa-miR-454-3p | ACSL4 | 1.37 | 0.14233 | -0.96 | 0.51944 | MirTarget; miRNATAP | -0.14 | 0.04315 | NA | |
7 | hsa-miR-32-5p | ACTC1 | 2.95 | 0.02657 | -6.29 | 2.0E-5 | MirTarget | -0.56 | 0.00053 | NA | |
8 | hsa-miR-454-3p | ACVR1 | 1.37 | 0.14233 | -0.76 | 0.54869 | MirTarget; miRNATAP | -0.12 | 0.00599 | NA | |
9 | hsa-miR-17-5p | ACVRL1 | 2.33 | 0.30125 | -3.43 | 0.00079 | TargetScan | -0.23 | 0.0002 | NA | |
10 | hsa-miR-32-5p | ADAM22 | 2.95 | 0.02657 | -1.98 | 0.10406 | mirMAP | -0.36 | 0.01652 | NA | |
11 | hsa-miR-17-5p | ADAMTS5 | 2.33 | 0.30125 | -6.31 | 0 | TargetScan | -0.22 | 0.02546 | NA | |
12 | hsa-miR-32-5p | ADAMTSL1 | 2.95 | 0.02657 | -6 | 0 | miRNATAP | -0.53 | 4.0E-5 | NA | |
13 | hsa-miR-32-5p | ADAMTSL3 | 2.95 | 0.02657 | -3.45 | 0.01443 | MirTarget; miRNATAP | -0.53 | 0.00122 | NA | |
14 | hsa-miR-32-5p | ADCY1 | 2.95 | 0.02657 | -1.25 | 0.23905 | mirMAP | -0.28 | 0.02311 | NA | |
15 | hsa-miR-32-5p | ADCY5 | 2.95 | 0.02657 | -5.82 | 0.00016 | mirMAP | -0.46 | 0.01573 | NA | |
16 | hsa-miR-17-5p | AFF1 | 2.33 | 0.30125 | -1.07 | 0.49725 | TargetScan | -0.11 | 0.00674 | NA | |
17 | hsa-miR-32-5p | AFF3 | 2.95 | 0.02657 | -4.85 | 0 | MirTarget | -0.43 | 0.00013 | NA | |
18 | hsa-miR-17-5p | AGFG2 | 2.33 | 0.30125 | -1.28 | 0.29482 | TargetScan; miRNATAP | -0.19 | 1.0E-5 | NA | |
19 | hsa-miR-32-5p | AHCYL1 | 2.95 | 0.02657 | -0.31 | 0.86149 | miRNATAP | -0.12 | 0.00017 | NA | |
20 | hsa-miR-17-5p | AHNAK | 2.33 | 0.30125 | -1.04 | 0.64703 | TargetScan; miRNATAP | -0.18 | 0.00111 | NA | |
21 | hsa-miR-454-3p | AKAP11 | 1.37 | 0.14233 | -0.66 | 0.63974 | miRNATAP | -0.12 | 0.00898 | NA | |
22 | hsa-miR-32-5p | AKAP12 | 2.95 | 0.02657 | -4.74 | 0.00166 | mirMAP | -0.46 | 0.00052 | NA | |
23 | hsa-miR-17-5p | AKAP13 | 2.33 | 0.30125 | -1.53 | 0.37244 | MirTarget; TargetScan; mirMAP; miRNATAP | -0.19 | 0 | NA | |
24 | hsa-miR-17-5p | AKT3 | 2.33 | 0.30125 | -3.26 | 0.00117 | TargetScan; miRNATAP | -0.17 | 0.02914 | NA | |
25 | hsa-miR-32-5p | ALPK3 | 2.95 | 0.02657 | 0.54 | 0.75673 | miRNATAP | -0.48 | 0.00131 | NA | |
26 | hsa-miR-454-3p | AMPD3 | 1.37 | 0.14233 | 1.49 | 0.13818 | MirTarget; miRNATAP | -0.28 | 3.0E-5 | NA | |
27 | hsa-miR-32-5p | ANGPTL2 | 2.95 | 0.02657 | -3.08 | 0.01213 | miRNATAP | -0.35 | 5.0E-5 | NA | |
28 | hsa-miR-17-5p | ANK2 | 2.33 | 0.30125 | -5.43 | 0 | MirTarget; miRNATAP | -0.6 | 0 | NA | |
29 | hsa-miR-32-5p | ANK3 | 2.95 | 0.02657 | -0.06 | 0.96651 | MirTarget | -0.27 | 0.00066 | NA | |
30 | hsa-miR-454-3p | ANKRD12 | 1.37 | 0.14233 | -0.46 | 0.71724 | MirTarget; miRNATAP | -0.11 | 0.01667 | NA | |
31 | hsa-miR-17-5p | ANKRD29 | 2.33 | 0.30125 | -2.22 | 0.05518 | MirTarget; TargetScan | -0.54 | 0 | NA | |
32 | hsa-miR-17-5p | ANKRD50 | 2.33 | 0.30125 | 0 | 0.99734 | MirTarget; TargetScan; miRNATAP | -0.16 | 0.00363 | NA | |
33 | hsa-miR-17-5p | ANXA11 | 2.33 | 0.30125 | -0.04 | 0.98232 | mirMAP | -0.11 | 0.00676 | NA | |
34 | hsa-miR-32-5p | APCDD1L | 2.95 | 0.02657 | -1.02 | 0.55328 | mirMAP | -0.64 | 0.00057 | NA | |
35 | hsa-miR-32-5p | APPL1 | 2.95 | 0.02657 | -0.48 | 0.73603 | miRNAWalker2 validate; MirTarget | -0.12 | 0.0043 | NA | |
36 | hsa-miR-17-5p | AR | 2.33 | 0.30125 | -4.67 | 0.00218 | mirMAP | -0.79 | 0 | 23095762 | miR 17 5p targets the p300/CBP associated factor and modulates androgen receptor transcriptional activity in cultured prostate cancer cells; Targeting of the 3'-untranslated region of PCAF mRNA by miR-17-5p caused translational suppression and RNA degradation and consequently modulation of AR transcriptional activity in PCa cells; Targeting of PCAF by miR-17-5p modulates AR transcriptional activity and cell growth in cultured PCa cells |
37 | hsa-miR-454-3p | AR | 1.37 | 0.14233 | -4.67 | 0.00218 | mirMAP; miRNATAP | -0.47 | 0.00625 | NA | |
38 | hsa-miR-17-5p | ARAP2 | 2.33 | 0.30125 | 1.85 | 0.12177 | MirTarget; TargetScan | -0.14 | 0.01554 | NA | |
39 | hsa-miR-454-3p | ARAP2 | 1.37 | 0.14233 | 1.85 | 0.12177 | MirTarget | -0.2 | 0.00207 | NA | |
40 | hsa-miR-454-3p | ARHGAP21 | 1.37 | 0.14233 | -0.06 | 0.96644 | MirTarget; miRNATAP | -0.14 | 0.01042 | NA | |
41 | hsa-miR-17-5p | ARHGAP24 | 2.33 | 0.30125 | -1.57 | 0.12603 | MirTarget | -0.23 | 0.01058 | NA | |
42 | hsa-miR-17-5p | ARHGAP26 | 2.33 | 0.30125 | -0.19 | 0.90211 | MirTarget; TargetScan; mirMAP; miRNATAP | -0.23 | 0.00209 | NA | |
43 | hsa-miR-17-5p | ARHGAP31 | 2.33 | 0.30125 | -2.29 | 0.00905 | TargetScan | -0.3 | 0 | NA | |
44 | hsa-miR-454-3p | ARHGEF12 | 1.37 | 0.14233 | -0.46 | 0.79305 | MirTarget; miRNATAP | -0.16 | 0.0003 | NA | |
45 | hsa-miR-32-5p | ARHGEF17 | 2.95 | 0.02657 | -2.26 | 0.08671 | miRNATAP | -0.26 | 1.0E-5 | NA | |
46 | hsa-miR-17-5p | ARHGEF3 | 2.33 | 0.30125 | -1.01 | 0.44523 | MirTarget; TargetScan; miRNATAP | -0.16 | 0.00015 | NA | |
47 | hsa-miR-32-5p | ARL10 | 2.95 | 0.02657 | -0.54 | 0.50161 | mirMAP | -0.28 | 0.00371 | NA | |
48 | hsa-miR-17-5p | ARL4C | 2.33 | 0.30125 | 1.91 | 0.17875 | MirTarget; TargetScan; miRNATAP | -0.15 | 0.03095 | NA | |
49 | hsa-miR-17-5p | ARSD | 2.33 | 0.30125 | 0 | 0.99908 | mirMAP | -0.32 | 0 | NA | |
50 | hsa-miR-17-5p | ASPA | 2.33 | 0.30125 | -5.59 | 0.00012 | mirMAP | -0.55 | 1.0E-5 | NA | |
51 | hsa-miR-454-3p | ASPA | 1.37 | 0.14233 | -5.59 | 0.00012 | mirMAP | -0.32 | 0.02559 | NA | |
52 | hsa-miR-454-3p | ASXL2 | 1.37 | 0.14233 | 0.94 | 0.44816 | MirTarget; miRNATAP | -0.2 | 0.03105 | NA | |
53 | hsa-miR-17-5p | ASXL3 | 2.33 | 0.30125 | -4.32 | 0.00164 | TargetScan | -0.39 | 0.00638 | NA | |
54 | hsa-miR-17-5p | ATF3 | 2.33 | 0.30125 | -0.68 | 0.67723 | miRNAWalker2 validate | -0.18 | 0.03451 | NA | |
55 | hsa-miR-17-5p | ATOH8 | 2.33 | 0.30125 | -5.62 | 0 | TargetScan | -0.36 | 0.00027 | NA | |
56 | hsa-miR-17-5p | ATP1A2 | 2.33 | 0.30125 | -7.07 | 0 | MirTarget; TargetScan | -0.72 | 0 | NA | |
57 | hsa-miR-32-5p | ATP2B4 | 2.95 | 0.02657 | -2.02 | 0.23283 | MirTarget | -0.16 | 0.00505 | NA | |
58 | hsa-miR-454-3p | ATP6V1B2 | 1.37 | 0.14233 | 0.31 | 0.84053 | MirTarget; miRNATAP | -0.1 | 0.00585 | NA | |
59 | hsa-miR-32-5p | ATP7A | 2.95 | 0.02657 | 0.03 | 0.97947 | miRNATAP | -0.12 | 0.02029 | NA | |
60 | hsa-miR-32-5p | ATP8B1 | 2.95 | 0.02657 | 0.87 | 0.59803 | miRNATAP | -0.16 | 0.0112 | NA | |
61 | hsa-miR-17-5p | ATXN1 | 2.33 | 0.30125 | -1.44 | 0.25265 | TargetScan; miRNATAP | -0.19 | 0.00016 | NA | |
62 | hsa-miR-32-5p | ATXN1 | 2.95 | 0.02657 | -1.44 | 0.25265 | miRNAWalker2 validate; miRNATAP | -0.13 | 0.03284 | NA | |
63 | hsa-miR-454-3p | ATXN1 | 1.37 | 0.14233 | -1.44 | 0.25265 | miRNATAP | -0.17 | 0.00303 | NA | |
64 | hsa-miR-32-5p | ATXN1L | 2.95 | 0.02657 | -0.17 | 0.89808 | miRNATAP | -0.14 | 0.00438 | NA | |
65 | hsa-miR-17-5p | ATXN7L1 | 2.33 | 0.30125 | -0.26 | 0.74464 | TargetScan | -0.18 | 0 | NA | |
66 | hsa-miR-32-5p | BAZ2B | 2.95 | 0.02657 | -0.62 | 0.62222 | miRNATAP | -0.12 | 0.00596 | NA | |
67 | hsa-miR-454-3p | BBX | 1.37 | 0.14233 | -0.17 | 0.90638 | MirTarget; miRNATAP | -0.1 | 0.02182 | NA | |
68 | hsa-miR-17-5p | BCAS1 | 2.33 | 0.30125 | -0.49 | 0.78808 | mirMAP | -0.86 | 0 | NA | |
69 | hsa-miR-17-5p | BCL6 | 2.33 | 0.30125 | -0.43 | 0.75836 | TargetScan | -0.16 | 0.0008 | NA | |
70 | hsa-miR-32-5p | BCL9 | 2.95 | 0.02657 | -1.03 | 0.45216 | miRNATAP | -0.11 | 0.02473 | NA | |
71 | hsa-miR-454-3p | BCL9L | 1.37 | 0.14233 | -0.07 | 0.96468 | mirMAP | -0.14 | 0.00577 | NA | |
72 | hsa-miR-454-3p | BHLHE40 | 1.37 | 0.14233 | 1.11 | 0.56907 | miRNAWalker2 validate | -0.24 | 0.00086 | NA | |
73 | hsa-miR-17-5p | BHLHE41 | 2.33 | 0.30125 | -1.42 | 0.31661 | TargetScan; miRNATAP | -0.44 | 1.0E-5 | NA | |
74 | hsa-miR-17-5p | BICC1 | 2.33 | 0.30125 | -2.29 | 0.08377 | TargetScan | -0.31 | 0.02277 | NA | |
75 | hsa-miR-32-5p | BICD1 | 2.95 | 0.02657 | -0.03 | 0.97414 | mirMAP | -0.21 | 0.00629 | NA | |
76 | hsa-miR-17-5p | BMPR2 | 2.33 | 0.30125 | -1.14 | 0.45199 | miRNAWalker2 validate; MirTarget; TargetScan; miRNATAP | -0.12 | 0.00049 | NA | |
77 | hsa-miR-32-5p | BMPR2 | 2.95 | 0.02657 | -1.14 | 0.45199 | miRNATAP | -0.15 | 0.00016 | NA | |
78 | hsa-miR-17-5p | BNC2 | 2.33 | 0.30125 | -6.05 | 0 | TargetScan; miRNATAP | -0.58 | 0 | NA | |
79 | hsa-miR-32-5p | BRMS1L | 2.95 | 0.02657 | 0.09 | 0.91727 | miRNATAP | -0.11 | 0.03586 | NA | |
80 | hsa-miR-454-3p | BRWD3 | 1.37 | 0.14233 | 2.17 | 0.04658 | MirTarget; miRNATAP | -0.2 | 0.01287 | NA | |
81 | hsa-miR-454-3p | BTBD10 | 1.37 | 0.14233 | 0.53 | 0.66167 | MirTarget | -0.18 | 3.0E-5 | NA | |
82 | hsa-miR-17-5p | BTG1 | 2.33 | 0.30125 | -0.79 | 0.64588 | TargetScan | -0.12 | 0.00371 | NA | |
83 | hsa-miR-454-3p | BTG1 | 1.37 | 0.14233 | -0.79 | 0.64588 | miRNATAP | -0.11 | 0.02771 | NA | |
84 | hsa-miR-17-5p | BTG2 | 2.33 | 0.30125 | -1.97 | 0.25098 | TargetScan | -0.11 | 0.04449 | NA | |
85 | hsa-miR-32-5p | BTG2 | 2.95 | 0.02657 | -1.97 | 0.25098 | MirTarget; miRNATAP | -0.17 | 0.0116 | 22266859 | Androgen regulated miR 32 targets BTG2 and is overexpressed in castration resistant prostate cancer; In conclusion androgen-regulated miR-32 is overexpressed in CRPC leading to reduced expression of BTG2 |
86 | hsa-miR-17-5p | BTN3A1 | 2.33 | 0.30125 | -0.3 | 0.82105 | miRNAWalker2 validate | -0.24 | 0.00014 | NA | |
87 | hsa-miR-409-3p | BTN3A2 | 0.28 | 0.79947 | -0.05 | 0.97293 | mirMAP | -0.13 | 0.01301 | NA | |
88 | hsa-miR-17-5p | C14orf28 | 2.33 | 0.30125 | -2.37 | 0.00011 | TargetScan; miRNATAP | -0.23 | 0 | NA | |
89 | hsa-miR-454-3p | C15orf52 | 1.37 | 0.14233 | -1.25 | 0.3319 | mirMAP | -0.36 | 0.00077 | NA | |
90 | hsa-miR-454-3p | C1S | 1.37 | 0.14233 | -1.82 | 0.27315 | MirTarget | -0.25 | 0.01612 | NA | |
91 | hsa-miR-409-3p | C1orf21 | 0.28 | 0.79947 | -1.12 | 0.41646 | PITA; mirMAP | -0.13 | 0.02071 | NA | |
92 | hsa-miR-32-5p | C1orf64 | 2.95 | 0.02657 | -2.7 | 0.12441 | mirMAP | -0.41 | 0.01751 | NA | |
93 | hsa-miR-32-5p | C20orf194 | 2.95 | 0.02657 | -1.84 | 0.07639 | miRNATAP | -0.27 | 2.0E-5 | NA | |
94 | hsa-miR-17-5p | C3orf70 | 2.33 | 0.30125 | -3.26 | 0.00156 | TargetScan | -0.21 | 0.04273 | NA | |
95 | hsa-miR-17-5p | CA10 | 2.33 | 0.30125 | -3.64 | 0.02709 | miRNATAP | -0.33 | 0.02235 | NA | |
96 | hsa-miR-32-5p | CACNA1H | 2.95 | 0.02657 | -6.12 | 0 | miRNATAP | -0.51 | 1.0E-5 | NA | |
97 | hsa-miR-32-5p | CADM1 | 2.95 | 0.02657 | -2.09 | 0.1387 | miRNATAP | -0.3 | 0.02273 | NA | |
98 | hsa-miR-17-5p | CALD1 | 2.33 | 0.30125 | -3.71 | 0.02146 | TargetScan; miRNATAP | -0.21 | 0.00428 | NA | |
99 | hsa-miR-32-5p | CALN1 | 2.95 | 0.02657 | -3.12 | 0.07468 | miRNATAP | -0.61 | 0.00053 | NA | |
100 | hsa-miR-32-5p | CAMK2A | 2.95 | 0.02657 | -4.27 | 0.00179 | MirTarget | -0.38 | 0.00666 | NA | |
101 | hsa-miR-17-5p | CAPN5 | 2.33 | 0.30125 | -1.94 | 0.26998 | mirMAP | -0.37 | 0.00205 | NA | |
102 | hsa-miR-17-5p | CASC4 | 2.33 | 0.30125 | -1.45 | 0.37749 | MirTarget | -0.14 | 0.0007 | NA | |
103 | hsa-miR-32-5p | CBFA2T2 | 2.95 | 0.02657 | 0.58 | 0.68302 | mirMAP | -0.15 | 0.00298 | NA | |
104 | hsa-miR-17-5p | CBX7 | 2.33 | 0.30125 | -3.22 | 0.00976 | mirMAP | -0.32 | 0 | NA | |
105 | hsa-miR-454-3p | CD109 | 1.37 | 0.14233 | 0.41 | 0.73596 | mirMAP | -0.3 | 0.02391 | NA | |
106 | hsa-miR-17-5p | CD226 | 2.33 | 0.30125 | 0.6 | 0.47807 | TargetScan | -0.32 | 6.0E-5 | NA | |
107 | hsa-miR-17-5p | CD69 | 2.33 | 0.30125 | -0.62 | 0.5233 | TargetScan; miRNATAP | -0.44 | 0 | NA | |
108 | hsa-miR-454-3p | CD69 | 1.37 | 0.14233 | -0.62 | 0.5233 | miRNATAP | -0.25 | 0.01834 | NA | |
109 | hsa-miR-454-3p | CDH11 | 1.37 | 0.14233 | -2.75 | 0.04281 | mirMAP | -0.48 | 7.0E-5 | NA | |
110 | hsa-miR-17-5p | CELF2 | 2.33 | 0.30125 | -2.38 | 0.01903 | TargetScan | -0.3 | 0.00014 | NA | |
111 | hsa-miR-17-5p | CHD9 | 2.33 | 0.30125 | -0.24 | 0.84856 | MirTarget; TargetScan; miRNATAP | -0.17 | 7.0E-5 | NA | |
112 | hsa-miR-32-5p | CHD9 | 2.95 | 0.02657 | -0.24 | 0.84856 | miRNATAP | -0.2 | 4.0E-5 | NA | |
113 | hsa-miR-454-3p | CHD9 | 1.37 | 0.14233 | -0.24 | 0.84856 | miRNATAP | -0.17 | 0.00054 | NA | |
114 | hsa-miR-17-5p | CHIC1 | 2.33 | 0.30125 | -1.78 | 0.08872 | TargetScan | -0.26 | 5.0E-5 | NA | |
115 | hsa-miR-17-5p | CIITA | 2.33 | 0.30125 | 0.67 | 0.63916 | mirMAP | -0.21 | 0.04302 | NA | |
116 | hsa-miR-32-5p | CLDN11 | 2.95 | 0.02657 | -3.47 | 0.00112 | MirTarget | -0.36 | 0.00427 | NA | |
117 | hsa-miR-17-5p | CLIC6 | 2.33 | 0.30125 | -0.19 | 0.92919 | mirMAP | -0.47 | 0.00962 | NA | |
118 | hsa-miR-454-3p | CLIP1 | 1.37 | 0.14233 | 0.42 | 0.78033 | MirTarget; miRNATAP | -0.21 | 7.0E-5 | NA | |
119 | hsa-miR-409-3p | CLYBL | 0.28 | 0.79947 | -0.96 | 0.26882 | miRNATAP | -0.14 | 0.0173 | NA | |
120 | hsa-miR-17-5p | CMKLR1 | 2.33 | 0.30125 | -2.3 | 0.0139 | TargetScan | -0.35 | 9.0E-5 | NA | |
121 | hsa-miR-17-5p | CNN1 | 2.33 | 0.30125 | -8.99 | 0 | TargetScan | -0.71 | 0 | NA | |
122 | hsa-miR-32-5p | CNTN1 | 2.95 | 0.02657 | -2.59 | 0.16326 | miRNATAP | -0.82 | 0.00019 | NA | |
123 | hsa-miR-32-5p | CNTN4 | 2.95 | 0.02657 | -4.67 | 6.0E-5 | miRNATAP | -0.67 | 0 | NA | |
124 | hsa-miR-32-5p | COL11A1 | 2.95 | 0.02657 | -0.69 | 0.72488 | MirTarget | -0.8 | 0.00046 | NA | |
125 | hsa-miR-32-5p | COL12A1 | 2.95 | 0.02657 | -2.11 | 0.24462 | miRNATAP | -0.38 | 0.00145 | NA | |
126 | hsa-miR-17-5p | COL1A1 | 2.33 | 0.30125 | -1.82 | 0.45918 | mirMAP | -0.33 | 0.00039 | NA | |
127 | hsa-miR-32-5p | COL1A2 | 2.95 | 0.02657 | -2.4 | 0.30049 | MirTarget; miRNATAP | -0.62 | 0 | NA | |
128 | hsa-miR-32-5p | COL5A1 | 2.95 | 0.02657 | -2.17 | 0.20473 | miRNATAP | -0.29 | 0.01728 | NA | |
129 | hsa-miR-17-5p | COL8A2 | 2.33 | 0.30125 | -0.42 | 0.72104 | mirMAP | -0.23 | 0.01147 | NA | |
130 | hsa-miR-17-5p | CORO2B | 2.33 | 0.30125 | -3.77 | 0.00099 | MirTarget; TargetScan; miRNATAP | -0.33 | 0.00536 | NA | |
131 | hsa-miR-454-3p | CPEB2 | 1.37 | 0.14233 | -0.45 | 0.66859 | miRNATAP | -0.16 | 0.01428 | NA | |
132 | hsa-miR-17-5p | CPEB3 | 2.33 | 0.30125 | -0.09 | 0.91502 | TargetScan; miRNATAP | -0.21 | 5.0E-5 | NA | |
133 | hsa-miR-32-5p | CPEB3 | 2.95 | 0.02657 | -0.09 | 0.91502 | MirTarget; miRNATAP | -0.15 | 0.01492 | NA | |
134 | hsa-miR-17-5p | CPEB4 | 2.33 | 0.30125 | -0.68 | 0.57172 | mirMAP | -0.18 | 0.00148 | NA | |
135 | hsa-miR-32-5p | CPEB4 | 2.95 | 0.02657 | -0.68 | 0.57172 | miRNAWalker2 validate; miRNATAP | -0.22 | 0.00068 | NA | |
136 | hsa-miR-454-3p | CPEB4 | 1.37 | 0.14233 | -0.68 | 0.57172 | miRNATAP | -0.16 | 0.01341 | NA | |
137 | hsa-miR-17-5p | CREB3L2 | 2.33 | 0.30125 | -2.18 | 0.1571 | mirMAP | -0.14 | 0.02334 | NA | |
138 | hsa-miR-454-3p | CRISPLD1 | 1.37 | 0.14233 | -3.16 | 0.0237 | MirTarget | -0.4 | 0.01665 | NA | |
139 | hsa-miR-17-5p | CROT | 2.33 | 0.30125 | 0.76 | 0.43857 | MirTarget | -0.29 | 0 | NA | |
140 | hsa-miR-17-5p | CRY2 | 2.33 | 0.30125 | -2.56 | 0.03317 | MirTarget; TargetScan; miRNATAP | -0.14 | 6.0E-5 | NA | |
141 | hsa-miR-17-5p | CRYBG3 | 2.33 | 0.30125 | -0.03 | 0.98149 | MirTarget; TargetScan; miRNATAP | -0.24 | 0.00055 | NA | |
142 | hsa-miR-17-5p | CSF1 | 2.33 | 0.30125 | -0.95 | 0.36961 | TargetScan; miRNATAP | -0.15 | 0.04971 | NA | |
143 | hsa-miR-454-3p | CSF1 | 1.37 | 0.14233 | -0.95 | 0.36961 | MirTarget; miRNATAP | -0.2 | 0.02018 | NA | |
144 | hsa-miR-32-5p | CTNNBIP1 | 2.95 | 0.02657 | 1.15 | 0.41935 | miRNATAP | -0.1 | 0.04497 | NA | |
145 | hsa-miR-17-5p | CTSK | 2.33 | 0.30125 | -3.24 | 0.01457 | MirTarget | -0.57 | 0 | NA | |
146 | hsa-miR-454-3p | CTSK | 1.37 | 0.14233 | -3.24 | 0.01457 | MirTarget | -0.47 | 0 | NA | |
147 | hsa-miR-32-5p | CTTNBP2 | 2.95 | 0.02657 | -5.52 | 7.0E-5 | miRNATAP | -0.39 | 0.02053 | NA | |
148 | hsa-miR-17-5p | CXCL14 | 2.33 | 0.30125 | 2.15 | 0.29887 | TargetScan | -0.63 | 0.00031 | NA | |
149 | hsa-miR-32-5p | CXXC5 | 2.95 | 0.02657 | -0.03 | 0.98488 | MirTarget | -0.46 | 0 | NA | |
150 | hsa-miR-17-5p | CXorf23 | 2.33 | 0.30125 | -0.34 | 0.66995 | mirMAP | -0.11 | 0.00156 | NA |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | TISSUE DEVELOPMENT | 119 | 1518 | 2.018e-16 | 9.392e-13 |
2 | REGULATION OF CELL DIFFERENTIATION | 115 | 1492 | 2.396e-15 | 3.538e-12 |
3 | CARDIOVASCULAR SYSTEM DEVELOPMENT | 76 | 788 | 3.041e-15 | 3.538e-12 |
4 | CIRCULATORY SYSTEM DEVELOPMENT | 76 | 788 | 3.041e-15 | 3.538e-12 |
5 | CELL DEVELOPMENT | 110 | 1426 | 1.028e-14 | 9.567e-12 |
6 | NEUROGENESIS | 108 | 1402 | 2.056e-14 | 1.594e-11 |
7 | ORGAN MORPHOGENESIS | 76 | 841 | 9.374e-14 | 6.231e-11 |
8 | MUSCLE TISSUE DEVELOPMENT | 39 | 275 | 1.989e-13 | 1.157e-10 |
9 | CELLULAR RESPONSE TO ENDOGENOUS STIMULUS | 84 | 1008 | 3.727e-13 | 1.927e-10 |
10 | POSITIVE REGULATION OF GENE EXPRESSION | 121 | 1733 | 4.781e-13 | 2.224e-10 |
11 | TISSUE MORPHOGENESIS | 56 | 533 | 5.344e-13 | 2.26e-10 |
12 | POSITIVE REGULATION OF BIOSYNTHETIC PROCESS | 123 | 1805 | 1.584e-12 | 6.143e-10 |
13 | POSITIVE REGULATION OF MOLECULAR FUNCTION | 122 | 1791 | 2.044e-12 | 7.316e-10 |
14 | HEART DEVELOPMENT | 50 | 466 | 4.546e-12 | 1.511e-09 |
15 | NEURON DIFFERENTIATION | 74 | 874 | 5.028e-12 | 1.56e-09 |
16 | CELLULAR RESPONSE TO ORGANIC SUBSTANCE | 123 | 1848 | 7.799e-12 | 2.268e-09 |
17 | EMBRYONIC MORPHOGENESIS | 54 | 539 | 9.133e-12 | 2.5e-09 |
18 | REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT | 114 | 1672 | 1.185e-11 | 3.063e-09 |
19 | REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 112 | 1656 | 3.064e-11 | 7.128e-09 |
20 | RESPONSE TO ENDOGENOUS STIMULUS | 102 | 1450 | 2.918e-11 | 7.128e-09 |
21 | MUSCLE STRUCTURE DEVELOPMENT | 46 | 432 | 4.34e-11 | 9.616e-09 |
22 | VASCULATURE DEVELOPMENT | 48 | 469 | 6.508e-11 | 1.377e-08 |
23 | REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 117 | 1784 | 7.132e-11 | 1.443e-08 |
24 | SKELETAL SYSTEM DEVELOPMENT | 47 | 455 | 7.55e-11 | 1.464e-08 |
25 | POSITIVE REGULATION OF CATALYTIC ACTIVITY | 104 | 1518 | 8.422e-11 | 1.568e-08 |
26 | EMBRYO DEVELOPMENT | 72 | 894 | 9.945e-11 | 1.714e-08 |
27 | REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION | 28 | 184 | 9.618e-11 | 1.714e-08 |
28 | REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION | 35 | 278 | 1.052e-10 | 1.748e-08 |
29 | EMBRYONIC ORGAN MORPHOGENESIS | 35 | 279 | 1.163e-10 | 1.866e-08 |
30 | REGULATION OF GTPASE ACTIVITY | 59 | 673 | 2.175e-10 | 3.373e-08 |
31 | ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS | 74 | 957 | 3.423e-10 | 5.139e-08 |
32 | CENTRAL NERVOUS SYSTEM DEVELOPMENT | 69 | 872 | 5.365e-10 | 7.801e-08 |
33 | INTRACELLULAR SIGNAL TRANSDUCTION | 104 | 1572 | 6.075e-10 | 8.566e-08 |
34 | POSITIVE REGULATION OF CELL COMMUNICATION | 102 | 1532 | 6.458e-10 | 8.838e-08 |
35 | BIOLOGICAL ADHESION | 77 | 1032 | 7.535e-10 | 1.002e-07 |
36 | REGULATION OF SYSTEM PROCESS | 48 | 507 | 9.202e-10 | 1.189e-07 |
37 | NEURON DEVELOPMENT | 58 | 687 | 1.3e-09 | 1.634e-07 |
38 | CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION | 48 | 513 | 1.359e-09 | 1.664e-07 |
39 | MORPHOGENESIS OF AN EPITHELIUM | 41 | 400 | 1.586e-09 | 1.892e-07 |
40 | TUBE DEVELOPMENT | 50 | 552 | 1.841e-09 | 2.142e-07 |
41 | POSITIVE REGULATION OF CELL DIFFERENTIATION | 65 | 823 | 1.898e-09 | 2.154e-07 |
42 | EMBRYONIC ORGAN DEVELOPMENT | 41 | 406 | 2.462e-09 | 2.727e-07 |
43 | POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 74 | 1004 | 2.828e-09 | 3.06e-07 |
44 | NEURON PROJECTION DEVELOPMENT | 49 | 545 | 3.435e-09 | 3.633e-07 |
45 | REGULATION OF CELL DEVELOPMENT | 65 | 836 | 3.538e-09 | 3.658e-07 |
46 | POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION | 24 | 162 | 3.648e-09 | 3.69e-07 |
47 | CARDIAC MUSCLE TISSUE DEVELOPMENT | 22 | 140 | 5.339e-09 | 5.285e-07 |
48 | TUBE MORPHOGENESIS | 35 | 323 | 6.047e-09 | 5.862e-07 |
49 | POSITIVE REGULATION OF DEVELOPMENTAL PROCESS | 80 | 1142 | 6.174e-09 | 5.862e-07 |
50 | EPITHELIUM DEVELOPMENT | 70 | 945 | 6.402e-09 | 5.957e-07 |
51 | POSITIVE REGULATION OF RESPONSE TO STIMULUS | 117 | 1929 | 7.555e-09 | 6.76e-07 |
52 | POSITIVE REGULATION OF CELL DEVELOPMENT | 44 | 472 | 7.509e-09 | 6.76e-07 |
53 | CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND | 62 | 799 | 8.952e-09 | 7.86e-07 |
54 | NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS | 62 | 801 | 9.833e-09 | 8.473e-07 |
55 | REGULATION OF PHOSPHORUS METABOLIC PROCESS | 102 | 1618 | 1.176e-08 | 9.95e-07 |
56 | REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS | 73 | 1021 | 1.308e-08 | 1.087e-06 |
57 | REGULATION OF PROTEIN MODIFICATION PROCESS | 106 | 1710 | 1.413e-08 | 1.138e-06 |
58 | REGULATION OF CELLULAR COMPONENT MOVEMENT | 60 | 771 | 1.418e-08 | 1.138e-06 |
59 | ACTIN FILAMENT BASED PROCESS | 42 | 450 | 1.6e-08 | 1.262e-06 |
60 | CELL CELL ADHESION | 51 | 608 | 1.658e-08 | 1.286e-06 |
61 | NEGATIVE REGULATION OF CELL DIFFERENTIATION | 51 | 609 | 1.749e-08 | 1.334e-06 |
62 | MOVEMENT OF CELL OR SUBCELLULAR COMPONENT | 85 | 1275 | 1.956e-08 | 1.468e-06 |
63 | ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY | 55 | 689 | 2.478e-08 | 1.83e-06 |
64 | CELLULAR COMPONENT MORPHOGENESIS | 66 | 900 | 2.628e-08 | 1.911e-06 |
65 | SENSORY ORGAN DEVELOPMENT | 44 | 493 | 2.743e-08 | 1.964e-06 |
66 | MUSCLE CELL DIFFERENTIATION | 28 | 237 | 3.178e-08 | 2.241e-06 |
67 | CELLULAR RESPONSE TO HORMONE STIMULUS | 47 | 552 | 3.906e-08 | 2.713e-06 |
68 | BLOOD VESSEL MORPHOGENESIS | 36 | 364 | 3.999e-08 | 2.736e-06 |
69 | LOCOMOTION | 76 | 1114 | 4.636e-08 | 3.126e-06 |
70 | CARDIOCYTE DIFFERENTIATION | 17 | 96 | 4.787e-08 | 3.182e-06 |
71 | NEURON PROJECTION MORPHOGENESIS | 38 | 402 | 5.581e-08 | 3.658e-06 |
72 | REGULATION OF HYDROLASE ACTIVITY | 86 | 1327 | 5.724e-08 | 3.699e-06 |
73 | POSITIVE REGULATION OF HYDROLASE ACTIVITY | 65 | 905 | 7.324e-08 | 4.669e-06 |
74 | NEGATIVE REGULATION OF CELL COMMUNICATION | 79 | 1192 | 8.35e-08 | 5.251e-06 |
75 | POSITIVE REGULATION OF CELL DEATH | 49 | 605 | 9.46e-08 | 5.869e-06 |
76 | NEGATIVE REGULATION OF GENE EXPRESSION | 93 | 1493 | 9.946e-08 | 6.068e-06 |
77 | RESPONSE TO HORMONE | 64 | 893 | 1.004e-07 | 6.068e-06 |
78 | REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY | 25 | 207 | 1.126e-07 | 6.63e-06 |
79 | NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 56 | 740 | 1.125e-07 | 6.63e-06 |
80 | EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING | 46 | 554 | 1.147e-07 | 6.67e-06 |
81 | HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES | 21 | 153 | 1.323e-07 | 7.599e-06 |
82 | NEGATIVE REGULATION OF RESPONSE TO STIMULUS | 86 | 1360 | 1.679e-07 | 9.526e-06 |
83 | HEART MORPHOGENESIS | 25 | 212 | 1.792e-07 | 1.005e-05 |
84 | POSITIVE REGULATION OF NEURON DIFFERENTIATION | 31 | 306 | 2.058e-07 | 1.14e-05 |
85 | NEGATIVE REGULATION OF CELL PROLIFERATION | 50 | 643 | 2.437e-07 | 1.334e-05 |
86 | POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS | 87 | 1395 | 2.572e-07 | 1.392e-05 |
87 | STRIATED MUSCLE CELL DIFFERENTIATION | 22 | 173 | 2.62e-07 | 1.401e-05 |
88 | CARDIAC MUSCLE CELL DIFFERENTIATION | 14 | 74 | 3.121e-07 | 1.65e-05 |
89 | NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS | 67 | 983 | 3.183e-07 | 1.664e-05 |
90 | REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION | 17 | 109 | 3.248e-07 | 1.679e-05 |
91 | CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES | 24 | 204 | 3.289e-07 | 1.682e-05 |
92 | HEAD DEVELOPMENT | 53 | 709 | 3.651e-07 | 1.847e-05 |
93 | CELLULAR RESPONSE TO NITROGEN COMPOUND | 42 | 505 | 3.935e-07 | 1.969e-05 |
94 | REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY | 16 | 99 | 4.37e-07 | 2.118e-05 |
95 | REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS | 16 | 99 | 4.37e-07 | 2.118e-05 |
96 | REGULATION OF OSSIFICATION | 22 | 178 | 4.318e-07 | 2.118e-05 |
97 | CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION | 34 | 368 | 4.77e-07 | 2.288e-05 |
98 | POSITIVE REGULATION OF LOCOMOTION | 37 | 420 | 4.872e-07 | 2.313e-05 |
99 | REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION | 32 | 337 | 5.662e-07 | 2.661e-05 |
100 | RESPONSE TO OXYGEN CONTAINING COMPOUND | 85 | 1381 | 6.208e-07 | 2.888e-05 |
101 | CELL PROJECTION ORGANIZATION | 62 | 902 | 6.772e-07 | 3.12e-05 |
102 | SKELETAL SYSTEM MORPHOGENESIS | 23 | 201 | 9.425e-07 | 4.3e-05 |
103 | REGULATION OF ACTIN FILAMENT BASED PROCESS | 30 | 312 | 9.801e-07 | 4.427e-05 |
104 | REGULATION OF CELL DEATH | 88 | 1472 | 1.308e-06 | 5.85e-05 |
105 | TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY | 22 | 190 | 1.325e-06 | 5.871e-05 |
106 | NEGATIVE REGULATION OF NITROGEN COMPOUND METABOLIC PROCESS | 90 | 1517 | 1.346e-06 | 5.909e-05 |
107 | REGULATION OF CELL ADHESION | 47 | 629 | 1.719e-06 | 7.405e-05 |
108 | SENSORY ORGAN MORPHOGENESIS | 25 | 239 | 1.717e-06 | 7.405e-05 |
109 | REGULATION OF NEURON DIFFERENTIATION | 43 | 554 | 1.802e-06 | 7.692e-05 |
110 | EAR MORPHOGENESIS | 16 | 112 | 2.388e-06 | 0.000101 |
111 | POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 59 | 876 | 2.434e-06 | 0.000102 |
112 | TELENCEPHALON DEVELOPMENT | 24 | 228 | 2.468e-06 | 0.0001025 |
113 | MUSCLE ORGAN DEVELOPMENT | 27 | 277 | 2.619e-06 | 0.0001078 |
114 | REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS | 24 | 229 | 2.665e-06 | 0.0001088 |
115 | REGULATION OF SODIUM ION TRANSPORT | 13 | 77 | 3.163e-06 | 0.000128 |
116 | BONE DEVELOPMENT | 19 | 156 | 3.26e-06 | 0.0001308 |
117 | RHYTHMIC PROCESS | 28 | 298 | 3.51e-06 | 0.0001396 |
118 | POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS | 66 | 1036 | 4.005e-06 | 0.0001566 |
119 | POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS | 66 | 1036 | 4.005e-06 | 0.0001566 |
120 | BEHAVIOR | 40 | 516 | 4.26e-06 | 0.0001652 |
121 | REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 52 | 750 | 4.339e-06 | 0.0001669 |
122 | INNER EAR MORPHOGENESIS | 14 | 92 | 4.757e-06 | 0.0001814 |
123 | CELL MOTILITY | 56 | 835 | 5.022e-06 | 0.0001884 |
124 | LOCALIZATION OF CELL | 56 | 835 | 5.022e-06 | 0.0001884 |
125 | POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION | 71 | 1152 | 5.386e-06 | 0.0002005 |
126 | CARTILAGE DEVELOPMENT | 18 | 147 | 5.448e-06 | 0.0002012 |
127 | FOREBRAIN DEVELOPMENT | 31 | 357 | 5.507e-06 | 0.0002018 |
128 | PROTEIN PHOSPHORYLATION | 61 | 944 | 6.09e-06 | 0.0002214 |
129 | CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT | 12 | 70 | 6.401e-06 | 0.0002309 |
130 | CONNECTIVE TISSUE DEVELOPMENT | 21 | 194 | 6.707e-06 | 0.0002401 |
131 | EAR DEVELOPMENT | 21 | 195 | 7.269e-06 | 0.0002562 |
132 | REGULATION OF MUSCLE SYSTEM PROCESS | 21 | 195 | 7.269e-06 | 0.0002562 |
133 | ANGIOGENESIS | 27 | 293 | 7.489e-06 | 0.0002616 |
134 | CARDIAC CELL DEVELOPMENT | 10 | 49 | 7.535e-06 | 0.0002616 |
135 | MULTICELLULAR ORGANISMAL SIGNALING | 16 | 123 | 8.244e-06 | 0.0002842 |
136 | POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 35 | 437 | 8.386e-06 | 0.0002869 |
137 | FORMATION OF PRIMARY GERM LAYER | 15 | 110 | 8.791e-06 | 0.0002986 |
138 | CIRCULATORY SYSTEM PROCESS | 31 | 366 | 9.096e-06 | 0.0003059 |
139 | REGULATION OF CELL MORPHOGENESIS | 41 | 552 | 9.138e-06 | 0.0003059 |
140 | APPENDAGE DEVELOPMENT | 19 | 169 | 1.059e-05 | 0.0003494 |
141 | LIMB DEVELOPMENT | 19 | 169 | 1.059e-05 | 0.0003494 |
142 | UROGENITAL SYSTEM DEVELOPMENT | 27 | 299 | 1.085e-05 | 0.0003555 |
143 | CELL JUNCTION ORGANIZATION | 20 | 185 | 1.127e-05 | 0.0003666 |
144 | RESPONSE TO NITROGEN COMPOUND | 56 | 859 | 1.15e-05 | 0.0003715 |
145 | POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS | 69 | 1135 | 1.159e-05 | 0.0003718 |
146 | MUSCLE CELL DEVELOPMENT | 16 | 128 | 1.377e-05 | 0.0004368 |
147 | POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION | 27 | 303 | 1.38e-05 | 0.0004368 |
148 | EXTRACELLULAR STRUCTURE ORGANIZATION | 27 | 304 | 1.464e-05 | 0.0004604 |
149 | REGULATION OF CELL SUBSTRATE ADHESION | 19 | 173 | 1.482e-05 | 0.0004628 |
150 | MESENCHYME DEVELOPMENT | 20 | 190 | 1.673e-05 | 0.0005189 |
151 | POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION | 14 | 103 | 1.808e-05 | 0.0005572 |
152 | MESONEPHROS DEVELOPMENT | 13 | 90 | 1.846e-05 | 0.000565 |
153 | CELL DEATH | 62 | 1001 | 1.883e-05 | 0.0005726 |
154 | POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION | 8 | 34 | 2.062e-05 | 0.0006229 |
155 | REGULATION OF KINASE ACTIVITY | 51 | 776 | 2.299e-05 | 0.0006902 |
156 | REGULATION OF CELL PROLIFERATION | 84 | 1496 | 2.473e-05 | 0.0007375 |
157 | NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS | 43 | 616 | 2.511e-05 | 0.0007443 |
158 | SMOOTH MUSCLE TISSUE DEVELOPMENT | 6 | 18 | 2.646e-05 | 0.0007793 |
159 | POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE | 16 | 135 | 2.7e-05 | 0.00079 |
160 | REGULATION OF EPITHELIAL CELL MIGRATION | 18 | 166 | 2.935e-05 | 0.0008419 |
161 | CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION | 18 | 166 | 2.935e-05 | 0.0008419 |
162 | ACTION POTENTIAL | 13 | 94 | 2.967e-05 | 0.0008419 |
163 | RESPONSE TO BMP | 13 | 94 | 2.967e-05 | 0.0008419 |
164 | CELLULAR RESPONSE TO BMP STIMULUS | 13 | 94 | 2.967e-05 | 0.0008419 |
165 | EMBRYONIC SKELETAL SYSTEM DEVELOPMENT | 15 | 122 | 3.097e-05 | 0.0008732 |
166 | POSITIVE REGULATION OF AXONOGENESIS | 11 | 69 | 3.152e-05 | 0.0008834 |
167 | OLFACTORY LOBE DEVELOPMENT | 8 | 36 | 3.225e-05 | 0.0008987 |
168 | POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT | 22 | 232 | 3.322e-05 | 0.0009199 |
169 | PALLIUM DEVELOPMENT | 17 | 153 | 3.549e-05 | 0.0009772 |
170 | KIDNEY EPITHELIUM DEVELOPMENT | 15 | 125 | 4.129e-05 | 0.00113 |
171 | GASTRULATION | 17 | 155 | 4.193e-05 | 0.001141 |
172 | POSITIVE REGULATION OF OSSIFICATION | 12 | 84 | 4.304e-05 | 0.001164 |
173 | CYTOSKELETON ORGANIZATION | 53 | 838 | 4.461e-05 | 0.0012 |
174 | REGULATION OF OSTEOBLAST DIFFERENTIATION | 14 | 112 | 4.695e-05 | 0.001256 |
175 | REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION | 10 | 60 | 4.848e-05 | 0.001289 |
176 | NEURON PROJECTION GUIDANCE | 20 | 205 | 5.011e-05 | 0.001325 |
177 | REGULATION OF CELL PROJECTION ORGANIZATION | 39 | 558 | 5.788e-05 | 0.001516 |
178 | REGULATION OF JNK CASCADE | 17 | 159 | 5.799e-05 | 0.001516 |
179 | CARDIAC CHAMBER DEVELOPMENT | 16 | 144 | 5.977e-05 | 0.001537 |
180 | MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL | 8 | 39 | 5.964e-05 | 0.001537 |
181 | POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION | 8 | 39 | 5.964e-05 | 0.001537 |
182 | TISSUE REMODELING | 12 | 87 | 6.127e-05 | 0.001566 |
183 | POSITIVE REGULATION OF KINASE ACTIVITY | 35 | 482 | 6.47e-05 | 0.001644 |
184 | REGULATION OF BLOOD CIRCULATION | 25 | 295 | 6.502e-05 | 0.001644 |
185 | DEVELOPMENTAL MATURATION | 19 | 193 | 6.789e-05 | 0.001708 |
186 | RESPONSE TO MECHANICAL STIMULUS | 20 | 210 | 7.032e-05 | 0.001759 |
187 | NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY | 13 | 102 | 7.09e-05 | 0.001764 |
188 | DEVELOPMENTAL GROWTH | 27 | 333 | 7.186e-05 | 0.001779 |
189 | MAINTENANCE OF CELL NUMBER | 15 | 132 | 7.79e-05 | 0.001918 |
190 | NEGATIVE REGULATION OF LOCOMOTION | 23 | 263 | 7.836e-05 | 0.001919 |
191 | GROWTH | 31 | 410 | 8.035e-05 | 0.001957 |
192 | MESODERM DEVELOPMENT | 14 | 118 | 8.371e-05 | 0.002029 |
193 | ENDOTHELIUM DEVELOPMENT | 12 | 90 | 8.581e-05 | 0.002058 |
194 | REGULATION OF CHEMOTAXIS | 18 | 180 | 8.55e-05 | 0.002058 |
195 | CARDIAC CHAMBER MORPHOGENESIS | 13 | 104 | 8.686e-05 | 0.002073 |
196 | MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL | 5 | 14 | 8.868e-05 | 0.002105 |
197 | REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE | 19 | 197 | 8.946e-05 | 0.002113 |
198 | REGULATION OF FAT CELL DIFFERENTIATION | 13 | 106 | 0.0001058 | 0.002487 |
199 | MORPHOGENESIS OF A BRANCHING STRUCTURE | 17 | 167 | 0.0001071 | 0.002504 |
200 | NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS | 10 | 66 | 0.0001119 | 0.002551 |
201 | NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS | 14 | 121 | 0.0001101 | 0.002551 |
202 | MESODERM MORPHOGENESIS | 10 | 66 | 0.0001119 | 0.002551 |
203 | NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY | 10 | 66 | 0.0001119 | 0.002551 |
204 | LENS DEVELOPMENT IN CAMERA TYPE EYE | 10 | 66 | 0.0001119 | 0.002551 |
205 | CELLULAR RESPONSE TO LIPID | 33 | 457 | 0.0001154 | 0.002607 |
206 | TRANSMISSION OF NERVE IMPULSE | 9 | 54 | 0.0001153 | 0.002607 |
207 | EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS | 12 | 93 | 0.0001184 | 0.002661 |
208 | REGULATION OF MAPK CASCADE | 43 | 660 | 0.0001219 | 0.002726 |
209 | REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION | 10 | 67 | 0.0001273 | 0.002835 |
210 | OLFACTORY BULB INTERNEURON DIFFERENTIATION | 5 | 15 | 0.0001291 | 0.002847 |
211 | VENOUS BLOOD VESSEL DEVELOPMENT | 5 | 15 | 0.0001291 | 0.002847 |
212 | CRANIAL SKELETAL SYSTEM DEVELOPMENT | 9 | 55 | 0.0001335 | 0.002931 |
213 | SINGLE ORGANISM BEHAVIOR | 29 | 384 | 0.0001379 | 0.003012 |
214 | CELLULAR RESPONSE TO PEPTIDE | 23 | 274 | 0.000145 | 0.003152 |
215 | TAXIS | 33 | 464 | 0.0001533 | 0.003317 |
216 | CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND | 33 | 465 | 0.0001595 | 0.003436 |
217 | REGULATION OF NEURON PROJECTION DEVELOPMENT | 30 | 408 | 0.0001702 | 0.003635 |
218 | STEM CELL DIFFERENTIATION | 18 | 190 | 0.0001703 | 0.003635 |
219 | ACTIN FILAMENT ORGANIZATION | 17 | 174 | 0.0001768 | 0.003757 |
220 | GLAND MORPHOGENESIS | 12 | 97 | 0.0001779 | 0.003762 |
221 | POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS | 80 | 1492 | 0.000179 | 0.003769 |
222 | CARDIAC MYOFIBRIL ASSEMBLY | 5 | 16 | 0.0001823 | 0.003821 |
223 | POSITIVE REGULATION OF MAPK CASCADE | 33 | 470 | 0.0001942 | 0.004053 |
224 | CELL PART MORPHOGENESIS | 41 | 633 | 0.0001972 | 0.004096 |
225 | REGULATION OF ION TRANSPORT | 39 | 592 | 0.0001994 | 0.004123 |
226 | EMBRYONIC CRANIAL SKELETON MORPHOGENESIS | 8 | 46 | 0.0002028 | 0.004164 |
227 | REGULATION OF STEM CELL DIFFERENTIATION | 13 | 113 | 0.0002032 | 0.004164 |
228 | SECOND MESSENGER MEDIATED SIGNALING | 16 | 160 | 0.0002079 | 0.004244 |
229 | CARDIAC SEPTUM DEVELOPMENT | 11 | 85 | 0.0002197 | 0.004405 |
230 | PALATE DEVELOPMENT | 11 | 85 | 0.0002197 | 0.004405 |
231 | CELL JUNCTION ASSEMBLY | 14 | 129 | 0.0002182 | 0.004405 |
232 | HEART PROCESS | 11 | 85 | 0.0002197 | 0.004405 |
233 | PHOSPHORYLATION | 68 | 1228 | 0.0002283 | 0.00456 |
234 | ENDOTHELIAL CELL DIFFERENTIATION | 10 | 72 | 0.0002345 | 0.004662 |
235 | EPITHELIAL CELL DIFFERENTIATION | 34 | 495 | 0.0002354 | 0.004662 |
236 | LIMBIC SYSTEM DEVELOPMENT | 12 | 100 | 0.0002377 | 0.004687 |
237 | TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 45 | 724 | 0.0002458 | 0.004825 |
238 | REGULATION OF MUSCLE CONTRACTION | 15 | 147 | 0.0002607 | 0.005097 |
239 | REGULATION OF SMOOTH MUSCLE CONTRACTION | 9 | 60 | 0.0002648 | 0.005112 |
240 | HIPPOCAMPUS DEVELOPMENT | 10 | 73 | 0.0002631 | 0.005112 |
241 | CHONDROCYTE DIFFERENTIATION | 9 | 60 | 0.0002648 | 0.005112 |
242 | NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS | 36 | 541 | 0.000287 | 0.005495 |
243 | NEGATIVE REGULATION OF PHOSPHATE METABOLIC PROCESS | 36 | 541 | 0.000287 | 0.005495 |
244 | CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION | 7 | 37 | 0.000295 | 0.005591 |
245 | REGULATION OF METAL ION TRANSPORT | 25 | 325 | 0.0002956 | 0.005591 |
246 | CARDIAC MUSCLE CELL ACTION POTENTIAL | 7 | 37 | 0.000295 | 0.005591 |
247 | MEMBRANE DEPOLARIZATION | 9 | 61 | 0.0003009 | 0.005668 |
248 | NEGATIVE REGULATION OF PHOSPHORYLATION | 30 | 422 | 0.0003034 | 0.005692 |
249 | EYE DEVELOPMENT | 25 | 326 | 0.0003096 | 0.005785 |
250 | RESPONSE TO PEPTIDE | 29 | 404 | 0.0003241 | 0.005992 |
251 | MESENCHYMAL CELL DIFFERENTIATION | 14 | 134 | 0.0003245 | 0.005992 |
252 | REGULATION OF PROTEIN IMPORT | 17 | 183 | 0.0003224 | 0.005992 |
253 | REGULATION OF TRANSPORT | 92 | 1804 | 0.0003272 | 0.006018 |
254 | ARTERY DEVELOPMENT | 10 | 75 | 0.0003292 | 0.006031 |
255 | RESPONSE TO CAFFEINE | 5 | 18 | 0.0003369 | 0.006147 |
256 | RESPONSE TO CYTOKINE | 44 | 714 | 0.0003449 | 0.006268 |
257 | COLLAGEN FIBRIL ORGANIZATION | 7 | 38 | 0.0003505 | 0.006322 |
258 | MESENCHYME MORPHOGENESIS | 7 | 38 | 0.0003505 | 0.006322 |
259 | POSITIVE REGULATION OF STEM CELL DIFFERENTIATION | 8 | 50 | 0.000368 | 0.006611 |
260 | IN UTERO EMBRYONIC DEVELOPMENT | 24 | 311 | 0.0003698 | 0.006619 |
261 | REGULATION OF MUSCLE CELL DIFFERENTIATION | 15 | 152 | 0.0003747 | 0.006679 |
262 | REGULATION OF CARTILAGE DEVELOPMENT | 9 | 63 | 0.0003854 | 0.006844 |
263 | REGULATION OF HEART CONTRACTION | 19 | 221 | 0.0003957 | 0.007001 |
264 | TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER | 15 | 153 | 0.000402 | 0.007085 |
265 | NEGATIVE REGULATION OF CELL GROWTH | 16 | 170 | 0.0004135 | 0.007261 |
266 | RESPONSE TO ORGANIC CYCLIC COMPOUND | 53 | 917 | 0.0004215 | 0.007372 |
267 | REGULATION OF EPITHELIAL CELL DIFFERENTIATION | 13 | 122 | 0.0004334 | 0.007553 |
268 | OLFACTORY BULB INTERNEURON DEVELOPMENT | 4 | 11 | 0.0004395 | 0.007631 |
269 | REGULATION OF ANATOMICAL STRUCTURE SIZE | 32 | 472 | 0.0004458 | 0.007711 |
270 | REGULATION OF CELLULAR COMPONENT BIOGENESIS | 46 | 767 | 0.00046 | 0.007928 |
271 | ACTIN FILAMENT BASED MOVEMENT | 11 | 93 | 0.0004849 | 0.008325 |
272 | CALCIUM ION IMPORT | 9 | 65 | 0.0004885 | 0.008356 |
273 | GLAND DEVELOPMENT | 28 | 395 | 0.0004979 | 0.008487 |
274 | REGULATION OF TRANSFERASE ACTIVITY | 54 | 946 | 0.0005004 | 0.008498 |
275 | BONE MORPHOGENESIS | 10 | 79 | 0.0005034 | 0.008518 |
276 | POSITIVE REGULATION OF CELL ADHESION | 27 | 376 | 0.0005111 | 0.008617 |
277 | TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY | 33 | 498 | 0.0005452 | 0.009157 |
278 | STEROID HORMONE MEDIATED SIGNALING PATHWAY | 13 | 125 | 0.000548 | 0.009172 |
279 | NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION | 8 | 53 | 0.0005529 | 0.009188 |
280 | MESONEPHRIC TUBULE MORPHOGENESIS | 8 | 53 | 0.0005529 | 0.009188 |
281 | HORMONE MEDIATED SIGNALING PATHWAY | 15 | 158 | 0.0005656 | 0.009365 |
282 | LUNG ALVEOLUS DEVELOPMENT | 7 | 41 | 0.000569 | 0.009389 |
283 | RELAXATION OF MUSCLE | 5 | 20 | 0.0005744 | 0.009444 |
284 | REGULATION OF TRANSCRIPTION FACTOR IMPORT INTO NUCLEUS | 11 | 95 | 0.0005823 | 0.009507 |
285 | TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY | 11 | 95 | 0.0005823 | 0.009507 |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | REGULATORY REGION NUCLEIC ACID BINDING | 67 | 818 | 2.294e-10 | 2.131e-07 |
2 | NUCLEIC ACID BINDING TRANSCRIPTION FACTOR ACTIVITY | 85 | 1199 | 1.11e-09 | 5.157e-07 |
3 | RNA POLYMERASE II TRANSCRIPTION FACTOR ACTIVITY SEQUENCE SPECIFIC DNA BINDING | 52 | 629 | 1.934e-08 | 3.593e-06 |
4 | GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY | 33 | 303 | 1.452e-08 | 3.593e-06 |
5 | MOLECULAR FUNCTION REGULATOR | 89 | 1353 | 1.636e-08 | 3.593e-06 |
6 | E BOX BINDING | 10 | 34 | 1.954e-07 | 3.025e-05 |
7 | TRANSCRIPTION FACTOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING | 32 | 328 | 3.092e-07 | 4.104e-05 |
8 | RHO GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY | 14 | 77 | 5.205e-07 | 6.045e-05 |
9 | TRANSCRIPTION FACTOR BINDING | 42 | 524 | 1.041e-06 | 0.0001075 |
10 | SMAD BINDING | 13 | 72 | 1.439e-06 | 0.0001337 |
11 | DOUBLE STRANDED DNA BINDING | 54 | 764 | 1.593e-06 | 0.0001345 |
12 | RAS GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY | 24 | 228 | 2.468e-06 | 0.000191 |
13 | TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC BINDING | 29 | 315 | 3.536e-06 | 0.0002361 |
14 | TRANSCRIPTION FACTOR ACTIVITY PROTEIN BINDING | 44 | 588 | 3.557e-06 | 0.0002361 |
15 | BHLH TRANSCRIPTION FACTOR BINDING | 8 | 28 | 4.269e-06 | 0.0002644 |
16 | CALMODULIN BINDING | 20 | 179 | 6.861e-06 | 0.0003984 |
17 | BETA CATENIN BINDING | 13 | 84 | 8.558e-06 | 0.0004677 |
18 | TRANSFORMING GROWTH FACTOR BETA BINDING | 6 | 16 | 1.214e-05 | 0.0005935 |
19 | ENZYME BINDING | 96 | 1737 | 1.163e-05 | 0.0005935 |
20 | KINASE ACTIVITY | 55 | 842 | 1.304e-05 | 0.0006034 |
21 | RECEPTOR SIGNALING PROTEIN ACTIVITY | 19 | 172 | 1.364e-05 | 0.0006034 |
22 | BINDING BRIDGING | 19 | 173 | 1.482e-05 | 0.0006258 |
23 | RNA POLYMERASE II TRANSCRIPTION FACTOR BINDING | 14 | 104 | 2.022e-05 | 0.0008166 |
24 | TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING | 22 | 226 | 2.218e-05 | 0.0008586 |
25 | ACTIVATING TRANSCRIPTION FACTOR BINDING | 10 | 57 | 3.059e-05 | 0.001093 |
26 | PROTEIN SERINE THREONINE KINASE ACTIVITY | 34 | 445 | 2.983e-05 | 0.001093 |
27 | ACTIN BINDING | 31 | 393 | 3.643e-05 | 0.001253 |
28 | CELL ADHESION MOLECULE BINDING | 19 | 186 | 4.1e-05 | 0.00136 |
29 | SEQUENCE SPECIFIC DNA BINDING | 62 | 1037 | 5.327e-05 | 0.001707 |
30 | PROTEIN KINASE ACTIVITY | 43 | 640 | 6.106e-05 | 0.001891 |
31 | ZINC ION BINDING | 67 | 1155 | 6.633e-05 | 0.001988 |
32 | CORE PROMOTER PROXIMAL REGION DNA BINDING | 29 | 371 | 7.566e-05 | 0.002197 |
33 | PROTEIN DIMERIZATION ACTIVITY | 66 | 1149 | 0.0001004 | 0.002825 |
34 | GROWTH FACTOR BINDING | 14 | 123 | 0.0001314 | 0.00359 |
35 | NUCLEOSIDE TRIPHOSPHATASE REGULATOR ACTIVITY | 26 | 329 | 0.0001471 | 0.003904 |
36 | TRANSFERASE ACTIVITY TRANSFERRING PHOSPHORUS CONTAINING GROUPS | 58 | 992 | 0.0001684 | 0.004346 |
37 | CYTOSKELETAL ADAPTOR ACTIVITY | 5 | 16 | 0.0001823 | 0.004577 |
38 | PROTEIN HOMODIMERIZATION ACTIVITY | 45 | 722 | 0.0002313 | 0.005396 |
39 | STEROID HORMONE RECEPTOR ACTIVITY | 9 | 59 | 0.0002323 | 0.005396 |
40 | ENZYME REGULATOR ACTIVITY | 56 | 959 | 0.000225 | 0.005396 |
41 | RNA POLYMERASE II ACTIVATING TRANSCRIPTION FACTOR BINDING | 7 | 36 | 0.0002467 | 0.00559 |
42 | TRANSCRIPTION FACTOR ACTIVITY DIRECT LIGAND REGULATED SEQUENCE SPECIFIC DNA BINDING | 8 | 48 | 0.0002754 | 0.006093 |
43 | CYTOSKELETAL PROTEIN BINDING | 49 | 819 | 0.0003198 | 0.006753 |
44 | KINASE BINDING | 39 | 606 | 0.0003186 | 0.006753 |
45 | CALCIUM ION BINDING | 43 | 697 | 0.0003923 | 0.007992 |
46 | TRANSCRIPTION COREPRESSOR ACTIVITY | 19 | 221 | 0.0003957 | 0.007992 |
47 | CYTOKINE BINDING | 11 | 92 | 0.0004415 | 0.008371 |
48 | RECEPTOR SIGNALING PROTEIN SERINE THREONINE KINASE ACTIVITY | 11 | 92 | 0.0004415 | 0.008371 |
49 | PLATELET DERIVED GROWTH FACTOR BINDING | 4 | 11 | 0.0004395 | 0.008371 |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | CELL JUNCTION | 82 | 1151 | 1.796e-09 | 1.049e-06 |
2 | ANCHORING JUNCTION | 45 | 489 | 7.514e-09 | 2.194e-06 |
3 | CYTOSKELETON | 113 | 1967 | 2.533e-07 | 4.932e-05 |
4 | CELL SUBSTRATE JUNCTION | 36 | 398 | 3.688e-07 | 5.385e-05 |
5 | MEMBRANE REGION | 73 | 1134 | 8.119e-07 | 9.483e-05 |
6 | CELL CELL CONTACT ZONE | 12 | 64 | 2.405e-06 | 0.000216 |
7 | NEURON PART | 77 | 1265 | 3.324e-06 | 0.000216 |
8 | NEURON PROJECTION | 62 | 942 | 2.834e-06 | 0.000216 |
9 | T TUBULE | 10 | 45 | 3.329e-06 | 0.000216 |
10 | MEMBRANE MICRODOMAIN | 27 | 288 | 5.447e-06 | 0.0003181 |
11 | NODE OF RANVIER | 6 | 15 | 7.823e-06 | 0.0004153 |
12 | CELL CELL JUNCTION | 32 | 383 | 8.661e-06 | 0.0004215 |
13 | INTRINSIC COMPONENT OF PLASMA MEMBRANE | 92 | 1649 | 1.255e-05 | 0.0005636 |
14 | POSTSYNAPSE | 31 | 378 | 1.721e-05 | 0.0007179 |
15 | CORTICAL CYTOSKELETON | 12 | 81 | 2.971e-05 | 0.001084 |
16 | PLASMA MEMBRANE REGION | 58 | 929 | 2.814e-05 | 0.001084 |
17 | CORTICAL ACTIN CYTOSKELETON | 10 | 58 | 3.579e-05 | 0.0011 |
18 | MAIN AXON | 10 | 58 | 3.579e-05 | 0.0011 |
19 | CELL PROJECTION | 96 | 1786 | 3.481e-05 | 0.0011 |
20 | SARCOLEMMA | 15 | 125 | 4.129e-05 | 0.001206 |
21 | SYNAPSE | 49 | 754 | 4.419e-05 | 0.001229 |
22 | PLASMA MEMBRANE RAFT | 12 | 86 | 5.457e-05 | 0.001449 |
23 | ACTIN CYTOSKELETON | 33 | 444 | 6.664e-05 | 0.001622 |
24 | ACTOMYOSIN | 10 | 62 | 6.483e-05 | 0.001622 |
25 | EXTRACELLULAR MATRIX | 32 | 426 | 7.011e-05 | 0.00163 |
26 | BASAL PART OF CELL | 9 | 51 | 7.258e-05 | 0.00163 |
27 | CELL CORTEX PART | 14 | 119 | 9.181e-05 | 0.001915 |
28 | PROTEINACEOUS EXTRACELLULAR MATRIX | 28 | 356 | 9.004e-05 | 0.001915 |
29 | I BAND | 14 | 121 | 0.0001101 | 0.002217 |
30 | AXON | 31 | 418 | 0.0001143 | 0.002224 |
31 | CONTRACTILE FIBER | 19 | 211 | 0.0002201 | 0.004146 |
32 | CELL SURFACE | 46 | 757 | 0.0003464 | 0.006321 |
33 | CELL LEADING EDGE | 26 | 350 | 0.0003868 | 0.006844 |
34 | NEURON SPINE | 13 | 121 | 4e-04 | 0.006871 |
35 | INTERCALATED DISC | 8 | 51 | 0.000423 | 0.007057 |
36 | VACUOLE | 64 | 1180 | 0.0006024 | 0.009507 |
37 | PROTEIN COMPLEX INVOLVED IN CELL ADHESION | 6 | 30 | 0.0005866 | 0.009507 |
38 | PARANODE REGION OF AXON | 4 | 12 | 0.0006407 | 0.009594 |
39 | BANDED COLLAGEN FIBRIL | 4 | 12 | 0.0006407 | 0.009594 |
40 | APICAL JUNCTION COMPLEX | 13 | 128 | 0.0006872 | 0.009997 |
41 | SYNAPSE PART | 38 | 610 | 0.0007018 | 0.009997 |
Num | Pathway | Pathview | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|---|
1 | Focal_adhesion_hsa04510 | 20 | 199 | 3.28e-05 | 0.001458 | |
2 | FoxO_signaling_pathway_hsa04068 | 15 | 132 | 7.79e-05 | 0.001458 | |
3 | Calcium_signaling_pathway_hsa04020 | 18 | 182 | 9.859e-05 | 0.001458 | |
4 | Signaling_pathways_regulating_pluripotency_of_stem_cells_hsa04550 | 15 | 139 | 0.0001402 | 0.001458 | |
5 | MAPK_signaling_pathway_hsa04010 | 24 | 295 | 0.0001691 | 0.001458 | |
6 | Regulation_of_actin_cytoskeleton_hsa04810 | 19 | 208 | 0.000183 | 0.001458 | |
7 | TGF_beta_signaling_pathway_hsa04350 | 11 | 84 | 0.0001975 | 0.001458 | |
8 | Cell_adhesion_molecules_.CAMs._hsa04514 | 15 | 145 | 0.0002243 | 0.001458 | |
9 | Apelin_signaling_pathway_hsa04371 | 14 | 137 | 0.0004075 | 0.001936 | |
10 | Hippo_signaling_pathway_hsa04390 | 15 | 154 | 0.000431 | 0.001936 | |
11 | Hippo_signaling_pathway_multiple_species_hsa04392 | 6 | 29 | 0.0004838 | 0.001936 | |
12 | TNF_signaling_pathway_hsa04668 | 12 | 108 | 0.0004869 | 0.001936 | |
13 | Oocyte_meiosis_hsa04114 | 13 | 124 | 0.0005072 | 0.001936 | |
14 | Endocytosis_hsa04144 | 20 | 244 | 0.0005213 | 0.001936 | |
15 | ECM_receptor_interaction_hsa04512 | 10 | 82 | 0.0006792 | 0.002355 | |
16 | cGMP_PKG_signaling_pathway_hsa04022 | 15 | 163 | 0.0007828 | 0.002544 | |
17 | mTOR_signaling_pathway_hsa04150 | 14 | 151 | 0.001076 | 0.00329 | |
18 | Gap_junction_hsa04540 | 10 | 88 | 0.001183 | 0.003418 | |
19 | cAMP_signaling_pathway_hsa04024 | 16 | 198 | 0.002101 | 0.005751 | |
20 | Wnt_signaling_pathway_hsa04310 | 13 | 146 | 0.002296 | 0.00597 | |
21 | Tight_junction_hsa04530 | 14 | 170 | 0.003272 | 0.008101 | |
22 | Phospholipase_D_signaling_pathway_hsa04072 | 12 | 146 | 0.006316 | 0.01493 | |
23 | Rap1_signaling_pathway_hsa04015 | 15 | 206 | 0.007439 | 0.01682 | |
24 | PI3K_Akt_signaling_pathway_hsa04151 | 22 | 352 | 0.008422 | 0.01825 | |
25 | ErbB_signaling_pathway_hsa04012 | 8 | 85 | 0.01109 | 0.02306 | |
26 | Ras_signaling_pathway_hsa04014 | 15 | 232 | 0.02026 | 0.04052 | |
27 | Sphingolipid_signaling_pathway_hsa04071 | 9 | 118 | 0.02594 | 0.04967 | |
28 | Apoptosis_hsa04210 | 10 | 138 | 0.02674 | 0.04967 | |
29 | Adherens_junction_hsa04520 | 6 | 72 | 0.04393 | 0.07878 | |
30 | Ferroptosis_hsa04216 | 4 | 40 | 0.05386 | 0.09336 | |
31 | Cellular_senescence_hsa04218 | 10 | 160 | 0.06217 | 0.1043 | |
32 | Jak_STAT_signaling_pathway_hsa04630 | 10 | 162 | 0.06642 | 0.1064 | |
33 | HIF_1_signaling_pathway_hsa04066 | 7 | 100 | 0.06755 | 0.1064 | |
34 | Autophagy_animal_hsa04140 | 8 | 128 | 0.08905 | 0.1362 | |
35 | Phagosome_hsa04145 | 9 | 152 | 0.09608 | 0.1389 | |
36 | p53_signaling_pathway_hsa04115 | 5 | 68 | 0.0962 | 0.1389 | |
37 | Cytokine_cytokine_receptor_interaction_hsa04060 | 14 | 270 | 0.1069 | 0.1503 | |
38 | Necroptosis_hsa04217 | 9 | 164 | 0.135 | 0.1848 | |
39 | Phosphatidylinositol_signaling_system_hsa04070 | 6 | 99 | 0.1442 | 0.1922 | |
40 | VEGF_signaling_pathway_hsa04370 | 4 | 59 | 0.1603 | 0.2084 | |
41 | Peroxisome_hsa04146 | 5 | 83 | 0.1764 | 0.2237 | |
42 | NF_kappa_B_signaling_pathway_hsa04064 | 5 | 95 | 0.2536 | 0.314 | |
43 | AMPK_signaling_pathway_hsa04152 | 6 | 121 | 0.2662 | 0.3219 | |
44 | Apoptosis_multiple_species_hsa04215 | 2 | 33 | 0.3319 | 0.3922 | |
45 | ABC_transporters_hsa02010 | 2 | 45 | 0.4824 | 0.5575 | |
46 | Notch_signaling_pathway_hsa04330 | 2 | 48 | 0.5167 | 0.5841 | |
47 | Neuroactive_ligand_receptor_interaction_hsa04080 | 10 | 278 | 0.5391 | 0.5965 | |
48 | Lysosome_hsa04142 | 4 | 123 | 0.6464 | 0.6926 | |
49 | Cell_cycle_hsa04110 | 4 | 124 | 0.6526 | 0.6926 | |
50 | Mitophagy_animal_hsa04137 | 2 | 65 | 0.6813 | 0.7085 |